Patent · US Expired

Compositions and methods for the therapy and diagnosis of lung cancer

US6759508B2 · kind B2 · utility

1Cited by
6References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2001
Grant dateJul 6, 2004
Priority date
Expiry dateMay 18, 2021

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for the therapy and diagnosis of cancer, particularly lung cancer, are disclosed. Illustrative compositions comprise one or more lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.